Drug class
Leukocyte Stimulating Factors
"Leukocyte Stimulating Factors" is an administrative and compendial drug classification—more formally recognized by standard compendia and regulatory bodies as colony-stimulating factors or hematopoietic growth factors. Read more about Leukocyte Stimulating Factors
34 drugs in this class 19 manufacturers
Drugs in Leukocyte Stimulating Factors
UDENYCA AUTOINJECTOR (pegfilgrastim-cbqv)
FULPHILA (pegfilgrastim-jmdb)
UDENYCA ONBODY (pegfilgrastim-cbqv)
UDENYCA (pegfilgrastim-cbqv)
UDENYCA AUTOINJECTOR (pegfilgrastim-cbqv)
UDENYCA ONBODY (pegfilgrastim-cbqv)
RYZNEUTA (efbemalenograstim alfa-vuxw)
UDENYCA ONBODY (pegfilgrastim-cbqv)
"Leukocyte Stimulating Factors" is an administrative and compendial drug classification—more formally recognized by standard compendia and regulatory bodies as colony-stimulating factors or hematopoietic growth factors.
These biologic agents act primarily by binding to specific cell-surface receptors on hematopoietic progenitor cells in the bone marrow, stimulating the proliferation, differentiation, and activation of white blood cells such as neutrophils and monocytes.
Clinically, they are used to prevent and manage severe neutropenia, reduce the risk of life-threatening infections following myelosuppressive chemotherapy or bone marrow transplantation, and treat hematopoietic acute radiation syndrome.
-
nih.gov
"Leukocyte Stimulating Factors" is an administrative and compendial drug classification—more formally recognized by standard compendia and regulatory bodies as colony-stimulating factors or hematopoietic growth factors These biologic agents act primarily by binding to specific cell-surface receptors on hematopoietic progenitor cells in the bone marrow, stimulating the proliferation, differentiation, and activation of white blood cells such as neutrophils and monocytes Clinically, they are used t...
-
connectrx.com
These biologic agents act primarily by binding to specific cell-surface receptors on hematopoietic progenitor cells in the bone marrow, stimulating the proliferation, differentiation, and activation of white blood cells such as neutrophils and monocytes Clinically, they are used to prevent and manage severe neutropenia, reduce the risk of life-threatening infections following myelosuppressive chemotherapy or bone marrow transplantation, and treat hematopoietic acute radiation syndrome
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.